FCE
Fiera Capital (Europe) Portfolio holdings
AUM $213M
1-Year Return
42.4%
This Quarter Return
-23.26%
1 Year Return
+42.4%
3 Year Return
+41.22%
5 Year Return
–
10 Year Return
–
AUM
$75.5M
AUM Growth
-$34.4M
(-31%)
Cap. Flow
-$7.87M
Cap. Flow
% of AUM
-10.43%
Top 10 Holdings %
Top 10 Hldgs %
77.8%
Holding
57
New
7
Increased
17
Reduced
9
Closed
5
Top Buys
| 1 |
Vipshop
VIPS
|
+$3.84M |
| 2 |
JD.com
JD
|
+$3.68M |
| 3 |
QIWI
QIWI PLC
QIWI
|
+$2.81M |
| 4 |
TAL Education Group
TAL
|
+$571K |
| 5 |
DexCom
DXCM
|
+$183K |
Top Sells
Sector Composition
| 1 | Communication Services | 34.85% |
| 2 | Consumer Staples | 22.59% |
| 3 | Consumer Discretionary | 14.44% |
| 4 | Financials | 13.05% |
| 5 | Healthcare | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Thermo Fisher Scientific
TMO
$179B
| $247K | 0.33% |
2,020
| – | – |
|
27
UnitedHealth
UNH
$308B
| $216K | 0.29% |
1,864
| – | – |
|
28
Banco Macro
BMA
$2.8B
| $211K | 0.28% |
5,495
| – | – |
|
|
MDVN
29
DELISTED
MEDIVATION, INC.
MDVN
| $210K | 0.28% |
4,948
+1,722
| +53% | +$73.1K |
|
30
Illumina
ILMN
$15.5B
| $204K | 0.27% |
1,198
+223
| +23% | +$38K |
|
|
31
DexCom
DXCM
$29.6B
| $183K | 0.24% |
+8,552
| New | +$183K |
|
32
Becton Dickinson
BDX
$53.4B
| $181K | 0.24% |
1,399
+323
| +30% | +$41.8K |
|
33
Bristol-Myers Squibb
BMY
$94.3B
| $180K | 0.24% |
3,032
| – | – |
|
34
Boston Scientific
BSX
$147B
| $170K | 0.23% |
10,326
+2,651
| +35% | +$43.6K |
|
|
LCI
35
DELISTED
Lannett Company, Inc.
LCI
| $169K | 0.22% |
+1,021
| New | +$169K |
|
36
Petrobras Class A
PBR.A
$76.9B
| $161K | 0.21% |
44,043
+3,304
| +8% | +$12.1K |
|
37
Regeneron Pharmaceuticals
REGN
$60.9B
| $158K | 0.21% |
341
| – | – |
|
38
Cardinal Health
CAH
$35.9B
| $157K | 0.21% |
2,049
+1,068
| +109% | +$81.8K |
|
|
IPXL
39
DELISTED
Impax Laboratories, Inc.
IPXL
| $139K | 0.18% |
3,949
| – | – |
|
40
Edwards Lifesciences
EW
$44.6B
| $138K | 0.18% |
5,820
+1,896
| +48% | +$45K |
|
|
VWR
41
DELISTED
VWR Corporation
VWR
| $138K | 0.18% |
+5,381
| New | +$138K |
|
|
ADMS
42
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $114K | 0.15% |
+6,812
| New | +$114K |
|
43
Abbott
ABT
$229B
| $112K | 0.15% |
2,767
+428
| +18% | +$17.3K |
|
44
Vale
VALE
$46.6B
| $100K | 0.13% |
23,885
-897
| -4% | -$3.76K |
|
45
Stryker
SYK
$144B
| $99K | 0.13% |
1,047
| – | – |
|
46
Amphastar Pharmaceuticals
AMPH
$1.27B
| $98K | 0.13% |
8,451
| – | – |
|
|
CELG
47
DELISTED
Celgene Corp
CELG
| $98K | 0.13% |
908
| – | – |
|
48
Incyte
INCY
$16.2B
| $94K | 0.12% |
857
| – | – |
|
49
Telefônica Brasil
VIV
$20.3B
| $78K | 0.1% |
+8,514
| New | +$78K |
|
50
IQVIA
IQV
$31.6B
| $68K | 0.09% |
973
| – | – |
|